
Clinical Trial Endpoints in Oncology
OncoPharm
00:00
Response Rate and Special Considerations
John Bazar explains objective response rate as activity evidence and discusses transplant, CAR-T, and CINV endpoint examples.
Play episode from 10:40
Transcript


